![Paul Cox](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Cox
Investor Relations Contact chez
DYNAVAX TECHNOLOGIES CORPORATION
Profil
Paul Cox is currently Senior Associate at Stern Investor Relations, Inc. since 2011, VP-Investor Relations & Corporate Communications at Dynavax Technologies Corp.
since 2023, and Head-Investor Relations & Communications at BioNTech US, Inc. Former positions include President & Director-Boston Chapter at National Investor Relations Institute, Head-Investor Relations at SAGE Therapeutics, Inc., Vice President-Investor Relations at Voyager Therapeutics, Inc. from 2019 to 2020, and Vice President-Investor Relations & Communications at Kymera Therapeutics, Inc. Education includes undergraduate studies at the University of Massachusetts and graduate studies at Harvard Extension School.
Postes actifs de Paul Cox
| Sociétés | Poste | Début |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Investor Relations Contact | 01/03/2023 |
| NEON THERAPEUTICS, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Corporate Officer/Principal | 01/01/2011 |
Anciens postes connus de Paul Cox
| Sociétés | Poste | Fin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2020 |
| SAGE THERAPEUTICS, INC. | Investor Relations Contact | 01/03/2019 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
| KYMERA THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de Paul Cox
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Finance |
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
